SHOCKWAVE MEDICAL INC (SWAV)       286.87  +7.91 (+2.84%)

Company Profile

Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 657 full-time employees. The company went IPO on 2019-03-07. The firm is engaged in medical device treatment of atherosclerotic cardiovascular disease (atherosclerosis) through its differentiated local delivery of sonic pressure waves for the treatment of calcified plaque, which refer to as intravascular lithotripsy (IVL). Its products for the treatment of peripheral artery disease (PAD) includes Shockwave M5 IVL catheter (M5 catheter) and Shockwave S4 IVL catheter (S4 catheter). Its product for the treatment of coronary artery disease (CAD) is Shockwave C2 IVL catheter (C2 catheter). M5 catheter is a five-emitter catheter for use in its IVL System in medium vessels for the treatment of above-the-knee PAD. S4 catheter is a four-emitter catheter for use in its IVL System in small vessels for the treatment of below-the-knee PAD. C2 catheter is a two-emitter catheter for use in its IVL System for the treatment of CAD.

Company Info

SHOCKWAVE MEDICAL INC

5403 Betsy Ross Dr

Santa Clara CALIFORNIA 95054

P: 15102794262.0

CEO: Douglas Godshall

Employees: 657

Website: https://shockwavemedical.com/